<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02281305</url>
  </required_header>
  <id_info>
    <org_study_id>22977 / 29-08-2014</org_study_id>
    <nct_id>NCT02281305</nct_id>
  </id_info>
  <brief_title>Post-MI PET Scan Imaging of Inflammation</brief_title>
  <official_title>Imaging of Inflammation in the Postischemic Myocardium: Effect of Anti-inflammatory Treatment With Colchicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>G.Gennimatas General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academy of Athens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>G.Gennimatas General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Restoring the patency of the coronary vessels and providing the ischemic myocardium with&#xD;
      reperfused blood can cause additional tissue damage. A key element of ischemia and&#xD;
      reperfusion (I/R) injury and major determinant of the evolution of damage in the affected&#xD;
      myocardium is the inflammatory response. The main objective of the study is to evaluate the&#xD;
      efficacy of colchicine in reducing I/R injury by effectively modulating the inflammatory&#xD;
      response in the reperfused myocardium.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of inflammation of the involved myocardium as assessed by the PET scan</measure>
    <time_frame>5 days post-MI</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Colchicine Active treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: Colchicine 2 mg loading dose; 0.5 mg bid for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drug: Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colchicine</intervention_name>
    <arm_group_label>Colchicine Active treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The study will enroll patients 18 years old or older&#xD;
&#xD;
          -  Who presented to the hospital within twelve (12) hours of the onset of chest pain -Who&#xD;
             had ST segment elevation &gt; 1 mm in two contiguous limb leads or ST segment elevation &gt;&#xD;
             2 mm in two consecutive precordial leads or new onset of left bundle branch block&#xD;
             (LBBB) in a twelve lead electrocardiogram and for whom the decision was made to be&#xD;
             taken to the cath lab to perform angioplasty of the coronary vessels.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Excluded patients:&#xD;
&#xD;
               -  with age &gt; 80 years old&#xD;
&#xD;
               -  with active inflammatory diseases, infectious diseases or known malignancy&#xD;
&#xD;
               -  under treatment with corticosteroids, anti-inflammatory agents or disease&#xD;
                  modifying agents&#xD;
&#xD;
               -  with known hypersensitivity-allergy to colchicine&#xD;
&#xD;
               -  under chronic treatment with colchicine&#xD;
&#xD;
               -  with severe renal failure (eGFR &lt; 30 ml/min/1.73 m2)&#xD;
&#xD;
               -  with hepatic failure (Child - Pugh class B or C)&#xD;
&#xD;
               -  presented with cardiac arrest&#xD;
&#xD;
               -  presented with ventricular fibrillation&#xD;
&#xD;
               -  presented with cardiogenic shock&#xD;
&#xD;
               -  with stent thrombosis&#xD;
&#xD;
               -  with angina within 48 hours before infarction&#xD;
&#xD;
               -  with previous myocardial infarction in the affected territory&#xD;
&#xD;
               -  with occlusion of the left main or left circumflex coronary or the right coronary&#xD;
                  artery or with evidence of coronary collaterals to the region at risk on initial&#xD;
                  coronary angiography (at the time of admission)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Constantinos Anagnostopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Biomedical Research Foundation of Academy of Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christos Angelidis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Athens General Hospital &quot;G. Gennimatas&quot;</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Spyridon Deftereos, MD</last_name>
    <phone>+302107768560</phone>
    <email>spdeftereos@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georgios Giannopoulos, MD</last_name>
    <phone>+302107768560</phone>
    <email>ggiann@med.uoa.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Athens General Hospital &quot;G. Gennimatas&quot;</name>
      <address>
        <city>Athens</city>
        <state>Attika</state>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>spyridon Deftereos, MD</last_name>
      <phone>+302107768560</phone>
      <email>spdeftereos@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>October 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2014</study_first_posted>
  <last_update_submitted>October 31, 2014</last_update_submitted>
  <last_update_submitted_qc>October 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>G.Gennimatas General Hospital</investigator_affiliation>
    <investigator_full_name>Spyridon Deftereos</investigator_full_name>
    <investigator_title>Director, Cardiac Catheterization Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colchicine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

